Table 3 Changes in the behavior and clinical risk factors at 6-months follow up (compared to baseline)
CR group (n = 57) | Usual care group (n = 69) | P a | |||
|---|---|---|---|---|---|
change | 95% CI | change | 95% CI | ||
Anxiety and depression | |||||
HADS anxiety score | −0.69 | −1.34, −0.46 | −0.31 | −1.18, 0.56 | <0.01 |
HADS depression score | −1.54 | −2.04, −1.04 | −0.54 | −1.27, 0.19 | 0.03 |
SF-12 | |||||
SF-12 PCS | 8.70 | 6.05, 11.34 | −3.4 | −5.72, −1.08 | <0.01 |
SF-12 MCS | 11.50 | 8.02, 14.98 | 1.9 | −0.44, 4.24 | <0.01 |
Exercise capacity | |||||
6MWT, m | 57.42 | 41.60, 73.20 | −9.8 | −33.60, 14.00 | <0.01 |
Modifying factors | |||||
Medication adherence | −23.2% | −37.3%, −14.1% | −17.6% | −25.3%, −7.7%, | 0.71 |
Current smoker, n, % | −12.6% | −18.5%, −5.9% | −9.7% | −12.0%, −2.3% | 0.51 |
weight | −1.6 | −5.0, 1.8 | −0.5 | −4.8, 3.8 | 0.82 |
BMI | −0.4 | −3.8, 3.0 | −0.2 | −1.3, 0.9 | 0.88 |